AristaMD announced the promotion of Julia Jezmir, M.D., MBA, to President while she continues to serve as Chief Medical Officer. The expanded leadership role is intended to support the company’s next phase of growth and strengthen its focus on helping risk-bearing primary care organizations improve specialty care access, patient outcomes, and cost management.
Jezmir has played a key role in shaping AristaMD’s clinical and operational strategies and has worked closely with primary care organizations to develop specialty care solutions aimed at improving care delivery. In her dual role as President and Chief Medical Officer, she will lead efforts to expand the company’s specialty care capabilities and clinical strategies while supporting its mission of reducing the total cost of care.
AristaMD has spent more than a decade providing virtual-first specialty care services and e-consult solutions to primary care organizations. Through its SpecialtyCare360 platform, the company enables primary care providers to connect patients with specialists and improve access to care through a network of more than 400 specialists across over 70 subspecialties, including cardiology, endocrinology, and musculoskeletal care.
The company said the leadership transition underscores its commitment to delivering clinically driven services that enhance specialty care access, coordination, and affordability as value-based care continues to gain momentum across the healthcare industry.
According to AristaMD, Jezmir has also helped establish a service delivery ecosystem and corporate culture that has contributed to high levels of satisfaction among both clients and employees. The company believes her combination of clinical expertise and business leadership positions AristaMD for continued growth and innovation.
KEY QUOTES:
“Julia has been the driving force behind our clinical and business innovation, architecting our clinical and operational strategy and collaborating with industry-leading PCP clients to develop high-impact, patient-centric, provider-focused specialty-care solutions. Equally important, she has developed an incredible service delivery ecosystem and culture which yields a top-quadrant net promoter score from both clients and employees. Her passion for truly helping our PCP clients along with her proven clinical and business leadership will take us to the next level of serving as the ‘easy button’ for specialty care, essential as value-based care continues to accelerate.”
Keith Pinter, CEO, AristaMD
“Julia’s leadership as President and Chief Medical Officer will help us accelerate our next phase of growth while continuing to deliver meaningful value for our customers and the patients they serve.”
Keith Pinter, CEO, AristaMD
“Julia’s appointment as President reflects the Board’s confidence in both her leadership and AristaMD’s strategic direction. Her ability to connect clinical excellence with operational discipline has helped position AristaMD for its next stage of growth and innovation. As the healthcare landscape continues to evolve, Julia’s leadership will help ensure the company remains focused on delivering meaningful value for the organizations and patients it serves.”
John Kuelper, Chairman Of The Board, AristaMD
